Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Bach

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|September 15, 2016
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICEMiriam Bach, Rupert Bauersachs
The Journal of the American Osteopathic Association|October 31, 2017
Effect of Osteopathic Cranial Manipulative Medicine on Visual FunctionAustin Bach, Miriam Bach, Stephanie Frankel
Journal of the American College of Cardiology|November 17, 2018
Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World StudiesPaulus Kirchhof, Miriam Bach, A John Camm
The Journal of the American Osteopathic Association|November 12, 2010
The perfect electronic medical record systemAustin Bach, Moishe B Singer, Miriam Bach
Cell Cycle (Georgetown, Tex.)|September 3, 2005
Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociationLüder Wiebusch, Miriam Bach, Ralf Uecker, et al.
Materials (Basel, Switzerland)|October 23, 2021
Investigation of Electromechanical Properties on 3-D Printed Piezoelectric Composite Scaffold StructuresTutu Sebastian, Miriam Bach, Andreas Geiger, et al.
Protein Engineering, Design & Selection : PEDS|July 6, 2004
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cellsPeter Hölig, Miriam Bach, Tina Völkel, et al.
Protein Engineering|February 26, 2004
Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligandsMiriam Bach, Peter Hölig, Eva Schlosser, et al.
Thrombosis Journal|September 7, 2018
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional studyAlexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2018
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS studyPierre Amarenco, Sylvia Haas, Susanne Hess, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|September 15, 2016
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICEMiriam Bach, Rupert Bauersachs
The Journal of the American Osteopathic Association|October 31, 2017
Effect of Osteopathic Cranial Manipulative Medicine on Visual FunctionAustin Bach, Miriam Bach, Stephanie Frankel
Journal of the American College of Cardiology|November 17, 2018
Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World StudiesPaulus Kirchhof, Miriam Bach, A John Camm
The Journal of the American Osteopathic Association|November 12, 2010
The perfect electronic medical record systemAustin Bach, Moishe B Singer, Miriam Bach
Cell Cycle (Georgetown, Tex.)|September 3, 2005
Human cytomegalovirus inactivates the G0/G1-APC/C ubiquitin ligase by Cdh1 dissociationLüder Wiebusch, Miriam Bach, Ralf Uecker, et al.
Materials (Basel, Switzerland)|October 23, 2021
Investigation of Electromechanical Properties on 3-D Printed Piezoelectric Composite Scaffold StructuresTutu Sebastian, Miriam Bach, Andreas Geiger, et al.
Protein Engineering, Design & Selection : PEDS|July 6, 2004
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cellsPeter Hölig, Miriam Bach, Tina Völkel, et al.
Protein Engineering|February 26, 2004
Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligandsMiriam Bach, Peter Hölig, Eva Schlosser, et al.
Thrombosis Journal|September 7, 2018
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional studyAlexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2018
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS studyPierre Amarenco, Sylvia Haas, Susanne Hess, et al.
Pageof 2